Enhanced Solubility Through API Processing

The development of new active pharmaceutical ingredients (APIs) is a lengthy and cost-intensive process. Therefore, it is crucial to avoid any potential risks that could limit the product's success. Currently, many APIs are not being commercialized due to their poor water solubility (classified as BCS class II and IV), which results in low bioavailability. With an estimated 70-80% of drugs under development being poorly water-soluble, finding effective solutions to this challenge is becoming increasingly important.

Solubility issues can be addressed through sophisticated pharmaceutical formulations. However, why wait until the later stages of development to optimize API solubility when you can enhance your API's performance from the very beginning? API processing offers a means to improve drug solubility without the need to restart API development from scratch. Various techniques have evolved and are available to be selected based on your specific API's characteristics and needs.

We provide you with high-quality chemical raw materials required for these techniques to allow you to focus on commercialization rather than solubilization. Access the full catalog to learn more.